Digestive & Intestinal Remedies (Pharmacies) - Canada

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$156.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.95%, resulting in a market volume of US$172.20m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$4.00 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Canada has been experiencing steady growth in recent years.

Customer preferences: Customers in Canada have shown a growing interest in natural and herbal remedies for digestive and intestinal issues. They are increasingly seeking out products that are made from organic ingredients and are free from artificial additives. This shift in preferences can be attributed to a growing awareness of the potential side effects of conventional medications and a desire for more natural and holistic approaches to healthcare.

Trends in the market: One of the major trends in the Digestive & Intestinal Remedies market in Canada is the increasing demand for probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and can alleviate symptoms such as bloating, gas, and diarrhea. The popularity of probiotics can be attributed to the growing body of scientific research supporting their effectiveness and the increasing awareness of the importance of gut health. Another trend in the market is the rising popularity of over-the-counter (OTC) digestive remedies. Many Canadians are opting for self-care and are relying on OTC products to manage their digestive issues. This trend can be attributed to the convenience and accessibility of OTC products, as well as the rising healthcare costs in the country. OTC digestive remedies offer a cost-effective and convenient solution for minor digestive issues.

Local special circumstances: Canada has a large aging population, which is driving the demand for digestive and intestinal remedies. As people age, they are more prone to digestive issues such as constipation, indigestion, and acid reflux. This demographic trend is expected to continue in the coming years, further fueling the growth of the Digestive & Intestinal Remedies market in Canada.

Underlying macroeconomic factors: The Canadian healthcare system is known for its universal healthcare coverage, which provides access to medical services for all residents. This ensures that Canadians have access to healthcare professionals who can diagnose and prescribe treatments for digestive and intestinal issues. The availability of healthcare services and the high level of healthcare coverage in Canada contribute to the growth of the Digestive & Intestinal Remedies market. In addition, the increasing disposable income of Canadians is also driving the growth of the market. As people have more disposable income, they are more likely to spend on healthcare products and services, including digestive and intestinal remedies. Overall, the Digestive & Intestinal Remedies market in Canada is experiencing growth due to changing customer preferences, increasing demand for probiotics and OTC remedies, the aging population, and the underlying macroeconomic factors such as universal healthcare coverage and increasing disposable income.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.